Cart0Item(s)

You have no items in your shopping cart.

Product was successfully added to your shopping cart.
  • MONTELUKAST (Singulair) 10 mg/tab, 30 tab/pack - Pharmaceutics MONTELUKAST (Singulair) 10 mg/tab, 30 tab/pack - Pharmaceutics

MONTELUKAST (Singulair) 10 mg/tab, 30 tab/pack

Quick Overview

MONTELUKAST (Singulair) 10 mg/tab, 30 tab/pack

In Stock
$25.00

Pay attention

Genuine branded medication

Private and confidential

No hidden fees

Free GLOBAL shipping for order over 50 USD

Details

MONTELUKAST

USES

  • Treat Asthma.
  • Exercise Induced Bronchospasm.
  • Allergic Rhinitis And Urticaria.
  • Exercise-Induced Bronchoconstriction.


100% original from Russian pharmaceutical company Vertex.
All packs are air tight sealed and expire up to 09.2021.
Photos of the product are for illustation purpose only and may vary according to the manufacturer.

DESCRIPTION
Montelukast belongs to a class of drugs called leukotriene receptor antagonists. A class of drugs is a group of medications that work in a similar way. These drugs are often used to treat similar conditions. Leukotriene receptor antagonists help decrease inflammation and nasal congestion. This can help prevent reactions to triggers by keeping the airways to your lungs open. This helps improve symptoms of asthma as well as seasonal and year-round allergies. It also helps prevent breathing problems during or after exercise.

PACKAGING

Active ingredient:


Excipients:
Lactose monohydrate - 115.0 mg Microcrystalline cellulose - 65.0 mg Croscarmellose sodium - 8.0 mg Magnesium stearate - 1.6 mg.

Film layer of the tablet: [hypromellose - 3.0000 mg, hyprolose (hydroxypropyl cellulose) - 1.1640 mg, talc - 1.1556 mg, titanium dioxide - 0.6522 mg, yellow iron oxide (iron oxide) - 0.0282 mg] or [dry mix for a film coating containing hypromellose (50%), hyprolysis (hydroxypropyl cellulose) (19.4%), talc (19.26%), titanium dioxide (10.87%), yellow iron oxide (iron oxide) (0.47 %)] - 6.0 mg.

DOSAGE
Orally with water before or after food. It is recommended to take the drug at the same time each day.

For the treatment of asthma, the drug should be taken in the evening. In the treatment of allergic rhinitis, the drug can be taken at any time of the day. Patients with asthma and allergic rhinitis should take one tablet once a day in the evening.

Adults and adolescents from 15 years old - 10 mg once a day.

General recommendations
The therapeutic effect of Montelukast on symptoms that reflect the course of bronchial asthma is manifested during the first day. Patients should continue to take Montelukast both during the period of achieving control of symptoms of bronchial asthma and during the exacerbation of the disease.

Special patient groups
For elderly patients, patients with renal failure, patients with impaired liver function of mild or moderate severity, dose adjustment is not required. The dose of the drug is the same for female and male patients.

PRECAUTIONS

  • Increased sensitivity to any of the components of the drug.
  • Do not give to childeren younget than 15 years (unless specifically prescribed by your doctor).
  • Lactase deficiency, lactose intolerance and glucose-galactose malabsorption. Use during pregnancy and during breastfeeding.

SIDE EFFECTS
In general, Montelukast is well tolerated. Side effects are usually mild and, as a rule, do not require discontinuation of the drug.

Disorders from the nervous system: headache, dizziness, drowsiness, paresthesia / hypesthesia, convulsions.

Disturbances from the heart: heart palpitations. Disorders from the respiratory system, chest and mediastinal organs: nosebleeds, pulmonary eosinophilia.

Mental disorders: agitation, including aggressive behavior or hostility, anxiety, depression, disorientation, impaired attention, pathological dreams, hallucinations, insomnia, memory disorders, psychomotor activity (including irritability, anxiety and tremor), somnambulism, suicidal thoughts and behavior, teaks.

Disorders from the gastrointestinal tract: diarrhea, dyspepsia, nausea, vomiting, pancreatitis, abdominal pain, thirst.

Disorders from the liver and biliary tract: increased activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), hepatitis (including cholestatic, hepatocellular and mixed liver lesions).

Disorders from the kidneys and urinary tract: enuresis in children.

Violations of the musculoskeletal and connective tissue: arthralgia, myalgia, including muscle cramps.

Disorders from the blood and lymphatic system: increased tendency to bleeding, thrombocytopenia.

Disorders from the skin and subcutaneous tissues: tendency to form hematomas, erythema nodosum, erythema multiforme, pruritus, rash, urticaria, angioedema.

Immune system disorders: hypersensitivity reactions, including anaphylaxis, eosinophilic liver infiltration. Infectious and parasitic diseases: upper respiratory tract infections.

General disorders and disorders at the injection site: asthenia (weakness) / fatigue, edema, pyrexia.

STORAGE
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.

QUESTIONS?
Ask us any questions about MONTELUKAST.

Additional Information

SKU rf376
The purpose of the medication Respiratory System Treatment
Weight kg. 0.03

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.

  1. Be the first to review this product

Write Your Own Review

How do you rate this product? *

 1 star2 stars3 stars4 stars5 stars
Price
Product description
Quality of goods